Can a common protein stop deadly bleeding in liver patients?
Disease control
Not yet recruiting
This study aims to see if adding a protein called albumin to standard treatment helps patients with severe liver disease who are experiencing life-threatening bleeding from enlarged veins. It will involve 60 adults with cirrhosis and active bleeding. Participants will be randomly…
Phase: PHASE3 • Sponsor: King George's Medical University • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC